Of the five growth factors evaluated, only IGFBP-1 was significantly elevated in patients with PAD who developed MACE within two years, compared to those who did not (20.66 [SD 3.91] vs. 13.94 [SD 3.80] pg/mL, p = 0.012). The gene discussed is IGFBP1; the disease is peripheral arterial disease.